An intravenous vaccine, manufactured from autologous dendritic cells, for the treatment of metastatic androgen-independent prostate cancer.
Horizon Scanning
It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:
- Is this emerging technology new or replacing an existing technology?
- Where is this technology in the FDA regulatory process?
- When will this technology be commercially available in the market?
- What is the projected use, cost, and financial impact of this technology?
Acrobot Sculptor
A computer-assisted bone cutting system controlled by the orthopedic surgeon and used to prepare the bone prior to receiving a knee implant during joint replacement surgery. Used following a computed tomography scan and in conjunction with the Acrobot Planner and Navigator Systems.
Vadimezan (ASA404, formerly DMXAA)
An intravenous, vascular disrupting agent for first- and second-line treatment of advanced non-small cell lung cancer.
Patupilone (EPO906)
An intravenous microtubule-stabilizing agent for recurrent ovarian, peritoneal, or fallopian cancer resistant to platinum or taxane agents.
SinuNase™ (Intranasal Amphotericin B)
An antifungal agent formulated for intranasal lavage to treat chronic rhinosinusitis in symptomatic patients with severe and persistent inflammation despite having undergone sinus surgery.
MONARC™ System Annuloplasty Device
A coronary sinus annuloplasty device for the treatment of functional mitral regurgitation, consisting of distal and proximal self-expanding anchors that are percutaneously implanted using a transjugular delivery system and connected by a gradually contracting bridge.
Alair® System for Bronchial Thermoplasty
A catheter device that delivers radiofrequency energy though a bronchoscope to reduce smooth muscle mass in airways of patients with severe asthma that cannot be adequately managed with current care agents.
Tanezumab (RN624)
An intravenous monoclonal antibody against nerve growth factor for relief of chronic osteoarthritis pain in the knee and hip.
AtriClip™ Gillinov-Cosgrove Left Atrial Appendage (LAA) Exclusion System
A rectangular-shaped clamp-like device indicated for left atrial appendage occlusion, and inserted during open cardiac surgery in patients with or at risk for atrial fibrillation.
Synergo® SB-TS 101.1 Device with Mitomycin C
A combination device/drug product that delivers local hyperthermia concomitantly with intravesical mitomycin C for adjuvant therapy following transurethral resection of superficial transitional cell carcinoma of the bladder in patients at intermediate or high risk for tumor recurrence.